The views of young adults and their parents on hormone treatment for short stature in adolescence

Hormone Research

Volumn 69, Issue 3, 2008, Pages 172-179

  Visser Van Balen, Hanneke ^a,b   Geenen, Rinie ^b,c   Looij, Janneke ^b   Huisman, Jaap ^d   Wit, Jan M ^e,f   Sinnema, Gerben ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f ESPE ^*

Author keywords

Gonadotropin releasing hormone agonist; Growth hormone; Idiopathic short stature; Patients' views; Small for gestational age

Indexed keywords

GONADORELIN AGONIST; GROWTH HORMONE;

ADOLESCENCE; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HUMAN; MALE; MEDICAL DECISION MAKING; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; SEMI STRUCTURED INTERVIEW; SHORT STATURE; SMALL FOR DATE INFANT; SOCIAL PSYCHOLOGY;

ADOLESCENT; ADULT; AFFECT; BODY HEIGHT; CHILD; FEMALE; FOLLOW-UP STUDIES; GROWTH DISORDERS; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; PARENTS; PERCEPTION; QUESTIONNAIRES; SELF CONCEPT; SELF EFFICACY;

EID: 38549144860     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112591     Document Type: Article

References (28)

1. Sandberg DE, Colsman M: Growth hormone treatment of short stature: status of the quality of life rationale. Horm Res 2005;63:275-283.
2. Bolt LL, Mul D: Growth hormone in short children: beyond medicine? Acta Paediatr 2001;90:69-73.
3. Macklin R: Ethical dilemmas in pediatric endocrinology: growth hormone for short normal children. J Pediatr Endocrinol Metab 2000;13(suppl 6):1349-1352.
4. Visser-van Balen H, Sinnema G, Geenen R: Growing up with idiopathic short stature: psychosocial development and hormone treatment: a critical review. Arch Dis Child 2006;91:433-439.
5. Hindmarsh PC, Dattani MT: Use of growth hormone in children. Nat Clin Pract Endocrinol Metab 2006;2:260-268.
6. Noeker M, Haverkamp F: Adjustment in conditions with short stature: a conceptual framework. J Pediatr Endocrinol Metab 2000;13:1585-1594.
7. Visser-van Balen H, Geenen R, Moerbeek M, Stroop R, Kamp GA, Huisman J, Wit JM, Sinnema G: Psychosocial functioning of adolescents with idiopathic short stature or persistent short stature born small for gestational age during three years of combined growth hormone and gonadotropin-releasing hormone agonist treatment. Horm Res 2005;64:77-87.
8. Kaplowitz PB: Editorial: If Gonadotropin-releasing hormone plus growth hormone (GH) really improves growth outcomes in short non-GH-deficient children, then what? J Clin Endocrinol Metab 2001;86:2965-2968.
9. Visser-van Balen H, Geenen R, Kamp GA, Huisman J, Wit JM, Sinnema G: Motives for choosing growth-enhancing hormone treatment in adolescents with idiopathic short stature: a questionnaire and structured interview study. BMC Pediatr 2005;5:15.
10. Visser-van Balen H, Geenen R, Kamp GA, Huisman J, Wit JM, Sinnema G: Long-term psychosocial consequences of hormone treatment for short stature. Acta Paediatr 2007; in press.
11. Ford S, Schofield T, Hope T: What are the ingredients for a successful evidence-based patient choice consultation? A qualitative study. Soc Sci Med 2003;56:589-602.
12. Harden A, Garcia J, Oliver S, Rees R, Shepherd J, Brunton G, Oakley A: Applying systematic review methods to studies of people's views: an example from public health research. J Epidemiol Community Health 2004;58:794-800.
13. Bensing J: Bridging the gap. The separate worlds of evidence-based medicine and patient-centered medicine. Patient Educ Couns 2000;39:17-25.
14. Singh J, Cuttler L, Shin M, Silvers JB, Neuhauser D: Medical decision-making and the patient: understanding preference patterns for growth hormone therapy using conjoint analysis. Med Care 1998;36:AS31-45.
15. Van Gool SA, Kamp GA, Visser-van Balen H, Mul D, Waelkens JJ, Jansen M, Verhoeven-Wind L, Delemarre-Van de Waal HA, De Muinck Keizer-Schrama SM, Leusink G, Roos JC, Wit JM: Final height outcome following 3 years of growth hormone and gonadotropin releasing hormone agonist treatment in short adolescents with relatively early puberty. J Clin Endocrinol Metab 2007; in press.
16. Ranke MB: Towards a consensus on the definition of idiopathic short stature. Horm Res 1996;45(suppl 2):64-66.
17. Chatelain P: Children born with intra-uterine growth retardation (IUGR) or small for gestational age (SGA): long term growth and metabolic consequences. Endocr Regul 2000;34:33-36.
18. Kamp GA, Mul D, Waelkens JJ, Jansen M, Delemarre-van de Waal HA, Verhoeven-Wind L, Frolich M, Oostdijk W, Wit JM: A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation. J Clin Endocrinol Metab 2001;86:2969-2975.
19. Hardt J, Rutter M: Validity of adult retrospective reports of adverse childhood experiences: review of the evidence. J Child Psychol Psychiatry 2004;45:260-273.
20. Manusco CA, Charlson ME: Does recollection error threaten the validity of cross-sectional studies of effectiveness? Med Care 1995;33:77-88.
21. Aseltine RH, Carlson KJ, Fowler FJ, Barry MJ: Comparing prospective and retrospective measurements of treatment outcomes. Med Care 1995;33:67-76.
22. Ross M: Relation of implicit theories to the construction of personal histories. Psychol Rev 1989;96:341-357.
23. Schmitt J, Di Fabio RP: The validity of prospective and retrospective global change criterion measures. Arch Phys Med Rehabil 2005;86:2270-2276.
24. Festinger L: A Theory of Cognitive Dissonance. Evanston, Row, Peterson, 1957.
25. Schacter DL, Chiao JY, Mitchell JP: The seven sins of memory, implications for self. Ann NY Acad Sci 2003;1001:226-239.
26. Van Overwalle F, Jordens K: An adaptive connectionist model of cognitive dissonance. Pers Soc Psychol Rev 2002;6:204-231.
27. Voss LD, Sandberg DE: The psychological burden of short stature: evidence against. Eur J Endocrinol 2004;151(suppl 1):S29-33.
28. Haverkamp F, Eiholzer U, Ranke MB, Noeker M: Symptomatic versus substitution growth hormone therapy in short children: from auxology towards a comprehensive multidimensional assessment of short stature and related interventions. J Pediatr Endocrinol Metab 2000;13:403-408.